Beauty Health Co/the (SKIN)

$3.27

Market is closed - opens 7 PM, 23 Apr 2024

Insights on Beauty Health Co/the

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 117.5M → 96.8M (in $), with an average decrease of 8.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -73.8M → -9.4M (in $), with an average increase of 685.1% per quarter

  • Vs CL

    In the last 1 year, Colgate-palmolive Co. has given 15.0% return, outperforming this stock by 89.8%

Performance

  • $3.21
    $3.36
    $3.27
    downward going graph

    1.99%

    Downside

    Day's Volatility :4.61%

    Upside

    2.68%

    downward going graph
  • $1.35
    $13.06
    $3.27
    downward going graph

    58.72%

    Downside

    52 Weeks Volatility :89.66%

    Upside

    74.96%

    downward going graph

Returns

PeriodBeauty Health Co/theSector (Consumer Staples)Index (Russel 2000)
3 Months
11.6%
3.7%
0.0%
6 Months
-29.68%
11.9%
0.0%
1 Year
-74.05%
-1.9%
-1.3%
3 Years
-73.82%
8.0%
-22.1%

Highlights

Market Capitalization
403.6M
Book Value
$0.48
Earnings Per Share (EPS)
-0.76
PEG Ratio
0.95
Wall Street Target Price
4.56
Profit Margin
-25.16%
Operating Margin TTM
-18.96%
Return On Assets TTM
-8.47%
Return On Equity TTM
-88.43%
Revenue TTM
398.0M
Revenue Per Share TTM
3.02
Quarterly Revenue Growth YOY
-1.3%
Gross Profit TTM
250.3M
EBITDA
-96.2M
Diluted Eps TTM
-0.76
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.1
EPS Estimate Next Year
0.04
EPS Estimate Current Quarter
-0.07
EPS Estimate Next Quarter
-0.06

Analyst Recommendation

Buy
    73%Buy
    26%Hold
    0
    0%Sell
Based on 19 Wall street analysts offering stock ratings for Beauty Health Co/the(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
13
12
Hold
5
5
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 39.45%

Current $3.27
Target $4.56

Company Financials

FY18Y/Y Change
Revenue
112.3M
-
Net Income
-317.0K
-
Net Profit Margin
-0.28%
-
FY19Y/Y Change
Revenue
166.6M
↑ 48.36%
Net Income
-1.6M
↑ 416.72%
Net Profit Margin
-0.98%
↓ 0.7%
FY20Y/Y Change
Revenue
119.1M
↓ 28.53%
Net Income
-29.2M
↑ 1681.14%
Net Profit Margin
-24.5%
↓ 23.52%
FY21Y/Y Change
Revenue
260.1M
↑ 118.39%
Net Income
-375.1M
↑ 1185.72%
Net Profit Margin
-144.22%
↓ 119.72%
FY22Y/Y Change
Revenue
365.9M
↑ 40.68%
Net Income
44.2M
↓ 111.79%
Net Profit Margin
12.09%
↑ 156.31%
FY23Y/Y Change
Revenue
398.0M
↑ 8.78%
Net Income
-100.1M
↓ 326.38%
Net Profit Margin
-25.16%
↓ 37.25%
Q3 FY22Q/Q Change
Revenue
88.8M
↓ 14.24%
Net Income
131.0K
↓ 97.93%
Net Profit Margin
0.15%
↓ 5.95%
Q4 FY22Q/Q Change
Revenue
98.1M
↑ 10.52%
Net Income
3.8M
↑ 2812.21%
Net Profit Margin
3.89%
↑ 3.74%
Q1 FY23Q/Q Change
Revenue
86.3M
↓ 12.06%
Net Income
-22.2M
↓ 681.91%
Net Profit Margin
-25.72%
↓ 29.61%
Q2 FY23Q/Q Change
Revenue
117.5M
↑ 36.15%
Net Income
3.4M
↓ 115.15%
Net Profit Margin
2.86%
↑ 28.58%
Q3 FY23Q/Q Change
Revenue
97.4M
↓ 17.11%
Net Income
-73.8M
↓ 2293.82%
Net Profit Margin
-75.77%
↓ 78.63%
Q4 FY23Q/Q Change
Revenue
96.8M
↓ 0.62%
Net Income
-9.4M
↓ 87.26%
Net Profit Margin
-9.71%
↑ 66.06%
FY19Y/Y Change
Total Assets
226.4M
-
Total Liabilities
227.6M
-
FY20Y/Y Change
Total Assets
222.8M
↓ 1.55%
Total Liabilities
252.8M
↑ 11.09%
FY21Y/Y Change
Total Assets
1.2B
↑ 446.95%
Total Liabilities
916.5M
↑ 262.55%
FY22Y/Y Change
Total Assets
1.0B
↓ 17.22%
Total Liabilities
837.4M
↓ 8.63%
FY23Y/Y Change
Total Assets
929.1M
↓ 7.91%
Total Liabilities
869.7M
↑ 3.86%
Q3 FY22Q/Q Change
Total Assets
1.1B
↓ 9.07%
Total Liabilities
846.9M
↓ 1.82%
Q4 FY22Q/Q Change
Total Assets
1.0B
↓ 8.68%
Total Liabilities
837.4M
↓ 1.12%
Q1 FY23Q/Q Change
Total Assets
994.9M
↓ 1.39%
Total Liabilities
847.3M
↑ 1.18%
Q2 FY23Q/Q Change
Total Assets
1.0B
↑ 1.27%
Total Liabilities
845.6M
↓ 0.2%
Q3 FY23Q/Q Change
Total Assets
973.1M
↓ 3.41%
Total Liabilities
883.2M
↑ 4.45%
Q4 FY23Q/Q Change
Total Assets
929.1M
↓ 4.52%
Total Liabilities
869.7M
↓ 1.53%
FY18Y/Y Change
Operating Cash Flow
-895.0K
-
Investing Cash Flow
-8.4M
-
Financing Cash Flow
11.2M
-
FY19Y/Y Change
Operating Cash Flow
1.7M
↓ 293.07%
Investing Cash Flow
-12.5M
↑ 47.81%
Financing Cash Flow
14.6M
↑ 30.58%
FY20Y/Y Change
Operating Cash Flow
-12.4M
↓ 819.68%
Investing Cash Flow
-3.8M
↓ 69.42%
Financing Cash Flow
18.3M
↑ 25.35%
FY21Y/Y Change
Operating Cash Flow
-28.4M
↑ 128.06%
Investing Cash Flow
-37.7M
↑ 888.5%
Financing Cash Flow
959.0M
↑ 5148.37%
FY22Y/Y Change
Operating Cash Flow
-106.6M
↑ 275.87%
Investing Cash Flow
-18.9M
↓ 49.99%
Financing Cash Flow
-205.2M
↓ 121.4%
Q3 FY22Q/Q Change
Operating Cash Flow
-31.4M
↑ 0.21%
Investing Cash Flow
-7.7M
↑ 58.66%
Financing Cash Flow
-100.0M
↑ 4950.51%
Q4 FY22Q/Q Change
Operating Cash Flow
-5.4M
↓ 82.83%
Investing Cash Flow
-2.8M
↓ 63.52%
Financing Cash Flow
-102.5M
↑ 2.48%
Q1 FY23Q/Q Change
Operating Cash Flow
-13.0M
↑ 141.24%
Investing Cash Flow
-21.7M
↑ 667.85%
Financing Cash Flow
-2.2M
↓ 97.86%
Q2 FY23Q/Q Change
Operating Cash Flow
22.0M
↓ 268.84%
Investing Cash Flow
-3.2M
↓ 85.15%
Financing Cash Flow
-1.5M
↓ 29.57%

Technicals Summary

Sell

Neutral

Buy

Beauty Health Co/the is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Beauty Health Co/the
Beauty Health Co/the
-20.44%
-29.68%
-74.05%
-73.82%
-73.82%
Colgate-palmolive Co.
Colgate-palmolive Co.
-0.35%
22.75%
13.42%
10.7%
28.0%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
5.93%
7.63%
-41.87%
-53.02%
-13.84%
Procter & Gamble Company, The
Procter & Gamble Company, The
0.22%
8.36%
2.68%
19.86%
55.62%
Kenvue Inc.
Kenvue Inc.
-5.18%
-0.51%
-27.21%
-27.21%
-27.21%
Kimberly-clark Corp.
Kimberly-clark Corp.
3.0%
5.85%
-9.48%
-2.41%
2.63%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Beauty Health Co/the
Beauty Health Co/the
49.42
NA
0.95
-0.1
-0.88
-0.08
NA
0.48
Colgate-palmolive Co.
Colgate-palmolive Co.
31.45
31.45
2.15
3.49
2.79
0.15
0.02
0.74
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
111.95
111.95
1.6
2.24
0.07
0.03
0.02
15.94
Procter & Gamble Company, The
Procter & Gamble Company, The
25.84
25.84
3.28
6.45
0.32
0.11
0.03
20.87
Kenvue Inc.
Kenvue Inc.
21.76
21.76
2.11
1.14
0.11
0.07
0.04
5.85
Kimberly-clark Corp.
Kimberly-clark Corp.
24.75
24.75
1.57
6.9
2.0
0.1
0.04
2.72
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Beauty Health Co/the
Beauty Health Co/the
Buy
$403.6M
-73.82%
49.42
-25.16%
Colgate-palmolive Co.
Colgate-palmolive Co.
Buy
$71.6B
28.0%
31.45
11.82%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
Buy
$51.8B
-13.84%
111.95
3.08%
Procter & Gamble Company, The
Procter & Gamble Company, The
Buy
$373.2B
55.62%
25.84
17.99%
Kenvue Inc.
Kenvue Inc.
Buy
$37.5B
-27.21%
21.76
10.77%
Kimberly-clark Corp.
Kimberly-clark Corp.
Hold
$43.4B
2.63%
24.75
8.63%

Institutional Holdings

  • FMR Inc

    13.66%

  • HHG PLC

    9.19%

  • Vanguard Group Inc

    5.91%

  • Luxor Capital Group, LP

    5.36%

  • Morgan Stanley - Brokerage Accounts

    5.12%

  • BlackRock Inc

    5.02%

Company Information

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Organization
Beauty Health Co/the
Employees
881
CEO
Ms. Marla Malcolm Beck
Industry
Consumer/Non-Cyclical

Discover More

FAQs